Cognitive impairment in treatment-refractory schizophrenia and type i diabetes. A case
Introduction Even when sharing etiologic factors, the incidence of DM-1 is low in patients with schizophrenia. Both diseases can lead to cognitive impairment, but its difficult to define its origin. 33 years old male, with DM-1 and schizophrenia referred to Therapeutic Community for psychotic symp...
Main Authors: | L. Soldado Rodriguez, S.S. Sánchez Rus, G.M. Ruiz Martinez, A. Alvarado Dafonte |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821013869/type/journal_article |
Similar Items
-
Cannabis use and cognitive impairment in schizophrenia
by: M. Gonçalves, et al.
Published: (2022-06-01) -
The role of the insula in cognitive impairment of schizophrenia
by: Susanna Gebhardt, et al.
Published: (2023-06-01) -
Cognitive impairments in schizophrenia and their impact on oxidative stress
by: A. S. Piatoikina, et al.
Published: (2022-10-01) -
Cognitive impairment among an Egyptian sample of patients with schizophrenia and bipolar disorders: a comparative study
by: Eman M. Khedr, et al.
Published: (2023-09-01) -
Mismatch negativity as an early biomarker of cognitive impairment in schizophrenia
by: Abeer Mamdouh Ali Mahmoud, et al.
Published: (2023-02-01)